Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model

The aim of the present study was to assess the potential barrier effect of Esoxx(®), a new nonprescription medication under development for the relief of gastroesophageal reflux symptoms. Esoxx is based on a mixture of hyaluronic acid and chondroitin sulfate in a bioadhesive suspension of Lutrol(®)...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Simone, Massimo P, Baldi, Fabio, Vasina, Valentina, Scorrano, Fabrizio, Bacci, Maria Laura, Ferrieri, Antonella, Poggioli, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387832/
https://www.ncbi.nlm.nih.gov/pubmed/22767997
http://dx.doi.org/10.2147/CEG.S31404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387832/
https://www.ncbi.nlm.nih.gov/pubmed/22767997
http://dx.doi.org/10.2147/CEG.S31404

Ejemplares similares